Treatment of laryngeal carcinoma in Germany
Modern methods of treatment of laryngeal carcinoma: from early diagnosis to organ-sparing therapy

Laryngeal carcinoma (cancer of the larynx) accounts for 3% of all cancers, with a predominance in men 50-70 years old. At RheinRegio Klinik Zentrum, they use functional-preserving techniques that allow total laryngectomy to be avoided in 80% of cases.
Symptoms of laryngeal carcinoma
Early signs:
- Hoarseness (lasts >2–3 weeks without improvement)
- Discomfort/pain in the throat when swallowing
- Foreign body sensation in the throat
Late symptoms:
- Difficulty breathing (stridor)
- Blood in saliva or sputum
- Enlarged lymph nodes on the neck
- Unpleasant smell from the mouth
- Weight loss for no reason
Rarely:
- Ear pain (referred)
- Voice change (aphonia)
Important: Hoarseness – key early symptom. If it persists for longer than 3 weeks, go to an ENT specialist immediately!
Diagnosis of laryngeal carcinoma at the RheinRegio Klinik Zentrum
Primary examination:
- Videolaryngoscopy (enlarged tumor visualization)
- Endoscopic biopsy with histological analysis
Visualization:
- CT scan of the neck and chest (estimate of size and prevalence)
- Soft tissue MRI (to determine cartilage/vascular invasion)
- PET-CT (detection of metastases)
Additional research:
- HPV testing (prognostic factor)
- Immunohistochemistry (PD-L1 status for immunotherapy)
Advantages of the clinic:
- Expert pathological analysis
- Fast deadlines receiving results (2-3 days)
- Individual plan treatment at the consultation
Each direction is supervised by advanced oncologists.
Find out the cost of treatment
To find out the approximate cost of treatment, answer a few questions and we will contact you!
Classification and stages of laryngeal carcinoma
By localization:
- Vocal cords (best prognosis)
- Epiglottis
- Subpharyngeal space (aggressive course)
- Vestibular department
Histological types:
- Squamous cell carcinoma (90% of cases)
- Less often: adenocarcinoma, sarcoma
Stages (TNM, 8th ed.):
- 0: carcinoma in situ
- I: Tumor ≤1 cm in one anatomical site
- II: Tumor >1 cm or spread to adjacent structures without fixation
- III: Vocal cord fixation or 1 affected lymph node ≤3 cm
- IV:
-
- IVA: Cartilage/soft tissue invasion of the neck
- IVB: Spinal/great vessel involvement
- IVC: Distant metastases
Degree of differentiation (G):
- G1 (highly differentiated)
- G2 (moderate)
- G3 (low differentiated)
Note: HPV-associated tumors have a better prognosis.
Treatment options for laryngeal carcinoma
Early stages (T1-T2)
- Endoscopic laser resection (CO₂ laser)
- Radio wave ablation (for anterior commissures)
- Focused radiation therapy (up to 30 Gy)
Common forms (T3-T4)
- Organ-sparing chemoradiotherapy (with cisplatin)
- Partial laryngectomy with TRAM flap reconstruction
- Robot-assisted surgery (Da Vinci)
Metastatic disease
- Immunotherapy (Nivolumab, Pembrolizumab)
- Targeted drugs (Cetuximab)
Survival prognosis
- Localized forms: 85-90%
- Regional metastases: 50-60%
- Distant metastases: <15%
Forecast:
- Videoendoscopy for smokers after 40 years
- HPV vaccination (Gardasil 9)
- Genetic counseling for family history
For a second opinion, please submit a histological report and imaging data.
Why RheinRegio Klinik Zentrum?

- Competence Center for Head and Neck Tumors
- International protocols (ESMO, NCCN)
- Phase I-II clinical trials
- 3D radiotherapy planning












